Sangamo Therapeutics
Insider trading & Transactions

Last updated: 2 Jan 2014

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Sale	2 Jan 2014	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	15,000	N/A	N/A
Option	2 Jan 2014	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	15,000	N/A	N/A
Option	26 Dec 2013	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Option	26 Dec 2013	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Employee Stock Option (Right to Buy)	15,000	N/A	N/A
Sale	26 Dec 2013	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	13,000	N/A	N/A
Option	18 Dec 2013	LANPHIER EDWARD O II director director	Employee Stock Option (Right to Buy)	50,000	N/A	N/A
Option	18 Dec 2013	LANPHIER EDWARD O II director director	Common Stock	50,000	N/A	N/A
Sale	18 Dec 2013	LANPHIER EDWARD O II director director	Common Stock	50,000	N/A	N/A
Purchase	13 Dec 2013	RA CAPITAL MANAGEMENT, LLC 10 percent owner 10 percent owner	Common Stock	5,040	N/A	N/A
Purchase	12 Dec 2013	RA CAPITAL MANAGEMENT, LLC 10 percent owner 10 percent owner	Common Stock	9,600	N/A	N/A
Option	10 Dec 2013	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Employee Stock Option (Right to Buy)	10,000	N/A	N/A
Option	10 Dec 2013	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Common Stock	10,000	N/A	N/A
Sale	10 Dec 2013	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Common Stock	10,000	N/A	N/A
Sale	2 Dec 2013	CLEVELAND PAUL B director director	Common Stock	10,000	N/A	N/A
Option	2 Dec 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	15,000	N/A	N/A
Sale	2 Dec 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	15,000	N/A	N/A
Option	2 Dec 2013	CLEVELAND PAUL B director director	Common Stock	10,000	N/A	N/A
Option	2 Dec 2013	CLEVELAND PAUL B director director	Stock Option (Right to Buy)	10,000	N/A	N/A
Option	2 Dec 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Employee Stock Option (Right to Buy)	15,000	N/A	N/A
Option	26 Nov 2013	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Employee Stock Option (Right to Buy)	15,000	N/A	N/A
Sale	26 Nov 2013	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	12,000	N/A	N/A
Option	26 Nov 2013	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Sale	15 Nov 2013	LANPHIER EDWARD O II director director	Common Stock	25,000	N/A	N/A
Option	13 Nov 2013	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Employee Stock Option (Right to Buy)	10,000	N/A	N/A
Sale	13 Nov 2013	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Common Stock	10,000	N/A	N/A
Option	13 Nov 2013	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Common Stock	10,000	N/A	N/A
Option	5 Nov 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Employee Stock Option (Right to Buy)	7,000	N/A	N/A
Sale	5 Nov 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	7,000	N/A	N/A
Option	5 Nov 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	7,000	N/A	N/A
Option	1 Nov 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	8,000	N/A	N/A
Sale	1 Nov 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	8,000	N/A	N/A
Option	1 Nov 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Employee Stock Option (Right to Buy)	8,000	N/A	N/A
Option	28 Oct 2013	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Sale	28 Oct 2013	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	12,000	N/A	N/A
Option	28 Oct 2013	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Employee Stock Option (Right to Buy)	15,000	N/A	N/A
Option	21 Oct 2013	CLEVELAND PAUL B director director	Stock Option (Right to Buy)	10,000	N/A	N/A
Option	21 Oct 2013	CLEVELAND PAUL B director director	Common Stock	10,000	N/A	N/A
Sale	21 Oct 2013	CLEVELAND PAUL B director director	Common Stock	10,000	N/A	N/A
Sale	15 Oct 2013	LANPHIER EDWARD O II director director	Common Stock	25,000	N/A	N/A
Option	10 Oct 2013	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Employee Stock Option (Right to Buy)	10,000	N/A	N/A
Option	10 Oct 2013	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Common Stock	10,000	N/A	N/A
Sale	10 Oct 2013	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Common Stock	10,000	N/A	N/A
Option	1 Oct 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Employee Stock Option (Right to Buy)	15,000	N/A	N/A
Option	1 Oct 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	15,000	N/A	N/A
Sale	1 Oct 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	15,000	N/A	N/A
Sale	26 Sep 2013	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	12,000	N/A	N/A
Option	26 Sep 2013	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Option	26 Sep 2013	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Employee Stock Option (Right to Buy)	15,000	N/A	N/A
Sale	16 Sep 2013	LANPHIER EDWARD O II director director	Common Stock	25,000	N/A	N/A
Sale	10 Sep 2013	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Common Stock	10,000	N/A	N/A

Showing 550 to 600 of 1018 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Sangamo Therapeutics Insider trading & Transactions

Insider trading

Who is insider?

Similar companies insider trading:

Sangamo Therapeutics
Insider trading & Transactions